A new generation of plasma substitute. Hydroxyethyl Starch 130/0.4 reveals an ideal blood volume expansion efficiency superior to dextrin, human serum albumin or gelatin-based plasma volume expanders and a higher safety.
Specifications
- CP
- Hydroxyethyl Starch 130/0.4 produced in CREDIT CHEMWERTH, with an assay content of NLT 98.5% is successfully inspected by SFDA for GMP compliance.
Features
.an assay content of NLT 98.5%Main Products
Vecuromium Bromide Tizanidine Hydrochloride Epinastine Hydrochloride